Skip to main content
. 2023 Oct 17;73(736):e807–e815. doi: 10.3399/BJGP.2023.0150

Table 1.

Baseline characteristics by continuity of care quartiles after multiple imputation and weighting

Characteristic Total (N = 421 545) Quartile SMDa
UPCI <0.50 (N = 100 915) UPCI 0.50–0.70 (N = 107 971) UPCI 0.71–0.91 (N = 103 487) UPCI 0.92–1.00 (N = 109 172)
Sex, male, n (%) 183 050 (43.4) 43 966 (43.6) 47 071 (43.6) 44 917 (43.4) 47 097 (43.1) <0.01
Age, years, mean (SD) 64.0 (12.2) 63.8 (12.1) 63.9 (12.3) 64.2 (12.0) 64.2 (12.2) 0.03
Smoker, n (%) 22 692 (5.4) 5434 (5.4) 5602 (5.2) 5592 (5.4) 6064 (5.6) 0.02
SBP, mmHg, mean (SD) 134.6 (15.8) 134.7 (16.1) 134.4 (15.9) 134.6 (15.5) 134.7 (15.5) 0.02
DBP, mmHg, mean (SD) 76.3 (10.6) 76.5 (10.7) 76.3 (10.7) 76.3 (10.4) 76.3 (10.5) 0.02
Fasting glucose, mmol/L, mean (SD) 5.3 (0.6) 5.3 (0.6) 5.3 (0.6) 5.3 (0.6) 5.3 (0.5) <0.01
BMI, kg/m2, mean (SD) 25.2 (3.8) 25.2 (3.8) 25.2 (3.9) 25.1 (3.8) 25.1 (3.9) <0.01
LDL-C, mmol/L, mean (SD) 3.2 (0.8) 3.2 (0.8) 3.2 (0.8) 3.2 (0.8) 3.2 (0.8) <0.01
eGFR, ml/min/1.73m2, mean (SD) 102.5 (63.3) 102.8 (29.4) 102.4 (29.6) 102.4 (72.8) 102.5 (93.8) 0.01
CCI, mean (SD) 3.4 (2.8) 3.4 (2.8) 3.4 (2.8) 3.4 (2.8) 3.4 (2.8) 0.02
Use of anti-hypertensive drugs, n (%) 401 385 (95.2) 96 485 (95.6) 103 371 (95.7) 98 440 (95.1) 103 088 (94.4) 0.06
Use of lipid-lowering agents, n (%) 40 622 (9.6) 9741 (9.7) 10 459 (9.7) 9977 (9.6) 10 445 (9.6) <0.01
Number of appointments, mean (SD) 11.7 (4.9) 11.7 (5.5) 11.7 (4.9) 11.8 (4.4) 11.7 (4.6) 0.02
UPCI, mean (SD) 0.69 (0.24) 0.36 (0.08) 0.58 (0.06) 0.80 (0.06) 0.98 (0.03) NA
a

Standardised mean difference (SMD) listed is the largest SMD between any pairs of the groups. BMI = body mass index. CCI = Charlson comorbidity index. DBP = diastolic blood pressure. eGFR = estimated glomerular filtration rate. LDL-C = low-density lipoprotein — cholesterol. NA = not applicable. SBP = systolic blood pressure. SD = standard deviation. UPCI = usual provider of care index.